Neovasc Inc., a pioneer of novel technologies used to treat vascular disease, today presented results from the follow-up phase of the initial clinical trial of its Neovasc Reducer(TM) product at the stars and stripes banner College of Cardiology 2010 annual meeting. The Neovasc Reducer is a novel implantable product designed to treat heart disease career who suffer from
rebellious angina. The new data shows that three years after implantation of the Reducer, the majority of clients continued to show measurable upgrade
document.write("" in angina symptoms.
More: - Read More